Learn More
Medchemexpress LLC Gemigliptin tartrate | 1374639-74-3 | 99.5% | 639.45 | 5 MG

Supplier: Medchemexpress LLC HY14892A5MG
Gemigliptin tartrate is a highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. It exhibits potent anti-glycation properties and can be used for the research of advanced glycation end products (AGE)-related diabetic complications. This product is for research use only.
- Highly selective, reversible, and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor
- IC50 of 10.3 nM for human recombinant DPP-4
- Exhibits potent anti-glycation properties
- Useful for research of advanced glycation end products (AGE)-related diabetic complications
- Dose-dependently inhibits the formation of AGE-BSA
- Suppresses the cross-linking of preformed AGE-BSA with rat tail tendon collagen
- Inhibits AGEs formation and AGE cross-links in vivo
- Dose-dependently inhibits plasma DPP-4 activity in various animal models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.